The Adoption Gap in Healthcare (Part 4): Operational Barrier
Deal Closed, Finally. Still, Full Deployment Stays Open.
There is a moment in every healthcare technology commercialization that feels like the finish line - the signed contract, the formal kickoff call, the internal announcement from the health system champion. It feels like success. It is, in fact, the beginning of the hardest part.
Operational barriers are the final, and in some ways most treacherous, category of adoption friction. They are treacherous precisely because they are largely invisible during the commercial process. They surface only after commitment has been made and when both parties are invested.
In my experience, operational friction is the leading cause of slow adoption. Deals that close but never fully scale, pilots that never convert to enterprise agreements, and technologies that achieve 20% of their potential utilization and plateau there indefinitely.
A signed contract is not adoption. It is permission to begin the hard work of making adoption possible.
What Operational Barriers Look Like in Practice
Operational barriers are varied in their form but consistent in their impact. They slow momentum, frustrate clinical champions, erode confidence in the commercial team, and give competing technologies the opening they need.
In the diagnostics, the most common operational friction points include laboratory accreditation and compliance requirements that weren't fully scoped during the sales process, sample collection and logistics protocols that don't align with the institution's existing infrastructure, IT and data integration demands that exceed the health system's current technical capacity, staff training burdens that fall on already-stretched clinical and laboratory teams, and change management resistance from frontline staff who were not part of the decision process.
Each of these barriers has a common root: they were not anticipated, disclosed, or planned for during the commercial engagement. The commercial team sold the vision. The operational reality sets in as a surprise.
The Operational Readiness Assessment
The most effective mitigation strategy for operational barriers is deceptively simple: figure them out early. Before a contract is signed, before an implementation timeline is committed, the commercial team or its designated lead should conduct an operational readiness assessment, a structured, collaborative evaluation of the health system's readiness to deploy the technology at scale.
This assessment is not a checklist for the sales team. It is a genuine diagnostic conversation, conducted with the right operational stakeholders - lab directors, IT leaders, compliance officers, nursing informatics leads, and patient navigation staff about the specific requirements your technology places on their environment, and their current capacity to meet those requirements.
These conversations are designed to reveal gaps. That is the point. A gap identified before contract signature is a project plan. A gap discovered after implementation begins is a crisis.
The readiness assessment also serves a commercial purpose beyond risk mitigation. Health system stakeholders who participate in a thorough, transparent readiness conversation develop confidence in the commercial team's operational competence. They are being treated as partners, not targets. That trust is a durable commercial asset.
An operational gap identified before contract signature is a project plan. The same gap discovered after implementation begins is a crisis for both sides.
The Case for a Dedicated Customer Success Function
Only in a handful of companies do the 'Account Owners' stay involved with the implementation of what was sold. In much of healthcare technology commercialization, the handoff from sales to implementation is abrupt and poorly defined. The commercial team that built the relationship moves on to the next opportunity. An implementation team with no commercial context picks up an account they have never met. The health system, which made a decision based on a relationship and a vision, now finds itself dealing with a different set of people focused on technical execution.
This is a structural problem, and it requires a structural solution. The most operationally sophisticated healthcare technology companies I have observed have built a dedicated customer success function, a team that bridges the commercial and operational worlds, maintains relationship continuity through implementation, and owns adoption outcomes rather than just deployment completion.
Customer success in this context is not a support function. It is a commercial function and must work in close coordination with the account lead. Its metrics are utilization rates, expansion within accounts, and referenceability, not just ticket resolution times. Marketing leaders who advocate for this function, and who help define its role and success criteria, are investing in the long-term commercial engine of their organization.
Change Management as a Commercial Discipline
Perhaps the most underappreciated dimension of operational barriers is the human one. Technology adoption in health systems is, at its core, a change management challenge. It asks clinicians, lab professionals, technologists, and administrative staff to try new ways to learn new processes, trust new tools, and accept new workflows in environments where change matters for patient safety and health outcomes.
Marketing and commercial teams cannot outsource this challenge. The materials they create, the training programs they support, and the peer education initiatives they invest in are all change management interventions, whether or not they are labeled as such. A compelling video of a KOL explaining why they changed their practice is not just a marketing asset. It is a change management tool.
The most successful technology adoptions I have been part of shared a common characteristic: the commercial team understood that they were not just selling a product. They were asking an institution to change; they also must provide the sustained support that meaningful change requires.
Barrier Audit: Questions To Ask
Do you conduct an operational readiness assessment before contract signature, not after?
Have you mapped the specific operational requirements your technology places on a health system's lab, IT, and clinical teams?
Is there a customer success function in your organization that owns adoption outcomes, not just implementation completion?
Do your commercial materials include operational case studies, not just clinical ones?
Are frontline clinical and lab staff included in your stakeholder engagement strategy, or only decision-makers?
Closing Thoughts: The Adoption Gap Is a Leadership Problem
Across this series, I have argued that the four barriers to healthcare technology adoption — workflow, evidence, economic, and operational share a common characteristic: they are all, at their core, failures of strategic empathy.
Failures to understand the clinical environment deeply enough. Failures to build evidence strategies nuanced enough to address multiple audiences. Failures to engage the economic stakeholders with the rigor that the financial complexity demands. Failures to anticipate the operational realities that determine whether a signed contract becomes a scaled deployment.
The adoption gap is not a marketing function problem. It is a leadership problem. And it is one that the best marketing and commercial leaders in healthcare are uniquely positioned to close not by selling harder, but by understanding more deeply.
I hope this series has offered a useful framework to understand adoption gaps in healthcare with ideas to build the right strategies to address them.
I would welcome the conversation, whether you are grappling with one of these barriers or all four.